• Home
  • Dual treatment with FLT3 inhibitor SU11657 and doxorubicin increases survival of leukemic mice.

Dual treatment with FLT3 inhibitor SU11657 and doxorubicin increases survival of leukemic mice.

Author List
Lee BD, Sevcikova S, Kogan SC
Publication
Leukemia research
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1451523
Publication Year
2006
PubMed ID
17184839
Publication Title
Lee BD, Sevcikova S, Kogan SC. Dual treatment with FLT3 inhibitor SU11657 and doxorubicin increases survival of leukemic mice. Leuk Res. 2007 Aug; 31(8):1131-4.